Logo
x

Search category

Subscribe Now

GSK

GSK Reports the Results for Blenrep (belantamab mafodotin) in P-III Clinical Trial for the Treatment of Multiple Myeloma

GSK Reports the Results for Blenrep (belantamab mafodotin) in P-III Clinical Trial for the Treatment of Multiple Myeloma

  • November 27, 2023
GSK Reports Results of Jemperli in Combination with Chemotherapy in P-III Trial for the Treatment of Endometrial Cancer

GSK Reports Results of Jemperli in Combination with Chemotherapy in P-III Trial for the Treatment of Endometrial Cancer

  • October 30, 2023
GSK and Hansoh Signed a License Agreement for HS-20089 to Treat Gynaecologic Cancer

GSK and Hansoh Signed a License Agreement for HS-20089 to Treat Gynaecologic Cancer

  • October 23, 2023
GSK Receives the EMA’s CHMP Positive Opinion of Jemperli (dostarlimab) for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer

GSK Receives the EMA’s CHMP Positive Opinion of Jemperli (dostarlimab) for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Ca...

  • October 17, 2023
Top 20 Monoclonal Antibodies Based on 2022 Total Revenue 

Top 20 Monoclonal Antibodies Based on 2022 Total Revenue 

  • September 26, 2023
GSK Receives the US FDA’s Approval of Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia

GSK Receives the US FDA’s Approval of Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia

  • September 18, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.